Luminex's Q2 Revenues Inch Up 1 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Luminex reported after the close of the market Monday that its second-quarter revenues inched up 1 percent as a decline in systems and consumables sales was offset by a sharp rise in assay revenue.

The Austin, Texas-based firm reported total revenues of $48.3 million for the three months ended June 30, compared to $47.7 million for the second quarter of 2011. It missed Wall Street's consensus estimate for revenues of $49.2 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.